CCNE1 and CCNF were respectively associated with BCL2L12 and PLK1. BCL2L12 is a potential new biomarker for colon cancer (49) and its transcript variant BCL2L12A might be a cell cycle regulator that interferes with G2-M transition (50). This evidence concerns the gene BCL2L12 and colonic neoplasm.